Abstract
Recently, many efforts have been devoted to investigating the application of functionalized micelles as targeted drug delivery carriers. In this study, glycyrrhetinic acid (GA, a liver targeting ligand) modified poly(ethylene glycol)-b-poly(γ-benzyl l-glutamate) micelles were prepared and evaluated as a potential liver-targeted drug carrier. The aggregation behavior, stability, size and morphology of the micelles were investigated. Anticancer drug doxorubicin (DOX) was encapsulated in the micelles. The drug release profile, in vivo distribution and the cytotoxicity against hepatic carcinoma QGY-7703 cells of DOX-loaded micelles were studied. The results indicated that the release profile was pH-dependent with Fickian diffusion kinetics. The micelles were remarkably targeted to the liver, inducing a 4.9-fold higher DOX concentration than that for free DOX·HCl. The DOX-loaded micelles exhibited almost twofold more potent cytotoxicity compared with DOX·HCl, and the cytotoxicity was time- and dosage-dependent. These results suggest that GA-functionalized micelles represent a promising carrier for drug delivery to the liver.
Similar content being viewed by others
References
Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp. 1975;51:135–53.
Soussan E, Cassel S, Blanzat M, et al. Drug delivery by soft matter: matrix and vesicular carriers. Angew Chem Int Ed. 2009;48:274–88.
Rapoport N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci. 2007;32:962–90.
Meng FH, Zhong ZY, Jan FJ. Stimuli-responsive polymersomes for programmed drug delivery. Biomacromolecules. 2009;10:197–209.
Nie Y, Zhang ZR, Li L, et al. Synthesis, characterization and transfection of a novel folate-targeted multipolymeric nanoparticles for gene delivery. J Mater Sci Mater Med. 2009;20:1849–57.
Chen ZN, Mi L, Xu J, et al. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (I-131) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol. 2006;65:435–44.
Petrak K. Essential properties of drug-targeting delivery systems. Drug Discov Today. 2005;10:1667–73.
Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev. 2002;54:169–90.
Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B Biointerfaces. 1999;16:3–27.
Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev. 2002;54:203–22.
Harada A, Kataoka K. Supramolecular assemblies of block copolymers in aqueous media as nanocontainers relevant to biological applications. Prog Polym Sci. 2006;31:949–82.
Haag R. Supermolecular drug-delivery systems based on polymeric core-shell architectures. Angew Chem Int Ed. 2004;43:278–82.
Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer. 2002;2:750–63.
Sutton D, Nasongkla N, Blanco E, et al. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 2007;24:1029–46.
Morell AG, Irvine RA, Sternlieb I, Scheinberg IH. Physical and chemical studies on ceruloplasmin. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem. 1968;243:155–9.
Liang HF, Chen CT, Chen SC, et al. Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials. 2006;27:2051–9.
Zhang J, Zhang QS, Chen XM, et al. Synthesis of a targeting drug for antifibrosis of liver; a conjugate for delivering glycyrrhetin to hepatic stellate cells. Glycoconj J. 2003;19:423–9.
Zhang YL, Wu Y, Yang WL, et al. Preparation, characterization, and drug release in vitro of chitosan-glycyrrhetic acid nanoparticles. J Pharm Sci. 2006;95:181–91.
Negishi M, Irie A, Nagata N, et al. Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochim Biophys Acta. 1991;1066:77–82.
Ismair MG, Stanca C, Ha HR, et al. Interactions of glycyrrhizin with organic anion transporting polypeptides of rat and human liver. Hepatol Res. 2003;26:343–7.
Zha RT, He XT, Du T, et al. Synthesis and Characterization of chitosan nanoparticles modified by glycyrrhetinic acid as a liver targeting drug carrier. Chem J Chin U. 2007;28:1098–100.
Tsuji H, Osaka S, Kiwada H. Targeting of liposomes surface-modified with glycyrrhizin to the liver. I. Preparation and biological disposition. Chem Pharm Bull. 1991;39:1004–8.
Tian Q, Wang XH, Wang W, et al. Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting. Int J Pharm. 2010;400:153–7.
Tian Q, Zhang CN, Wang XH, et al. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials. 2010;31:4748–56.
Lin AH, Liu YM, Huang Y, et al. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int J Pharm. 2008;359:247–53.
Mao SJ, Bi YQ, Jin H, et al. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazie. 2007;62:614–9.
Cha RT, Du T, Li JH, et al. Synthesis and characterization of polypeptide containing liver-targeting group. Polym Int. 2006;55:1057–62.
Daly WH, Phche D. The preparation of N-carboxyanhydrides of α-amino acids using bis(trichloromethyl) carbonate. Tetrahedron Lett. 1998;29:5859–62.
Van-Steenis JH, van Maarseveen EM, Verbaan FJ, et al. Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polymers. J Control Release. 2003;87:167–76.
Barbosa MEM, Montembault V, Cammas-Marion S, et al. Synthesis and characterization of novel poly(γ-benzyl-l-glutamate) derivatives tailored for the preparation of nanoparticles of pharmaceutical interest. Polym Int. 2007;56:317–24.
Vey E, Roger C, Meehan L, et al. Degradation mechanism of poly(lactic-co-glycolic) acid block copolymer cast films in phosphate buffer solution. Polym Degrad Stab. 2008;93:1869–76.
Jeong YI, Nah JW, Lee HC, et al. Adriamycin release from flower-type polymeric micelle based on star-block copolymer composed of poly(γ-benzyl l-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. Int J Pharm. 1999;188:49–58.
Huang CK, Lo CL, Chen HH, et al. Multifunctional micelles for cancer cell targeting, distribution imaging, and anticancer drug delivery. Adv Funct Mater. 2007;17:2291–7.
Peppas NA. A model of dissolution-controlled solute release from porous drug delivery polymeric systems. J Biomed Mater Res. 1983;17:1079–87.
Kim D, Gao ZG, Lee ES, et al. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer. Mol Pharm. 2009;6:1353–62.
Segura-Sánchez F, Montembault V, Fontaine L, et al. Synthesis and characterization of functionalized poly(γ-benzyl-l-glutamate) derivates and corresponding nanoparticles preparation and characterization. Int J Pharm. 2010;387:244–52.
Martinez-Barbosa ME, Cammas-Marion S, Bouteiller L, et al. PEGylated degradable composite nanoparticles based on mixtures of PEG-b-Poly(γ-benzyl l-glutamate) and poly(γ-benzyl l-glutamate). Bioconjug Chem. 2009;20:1490–6.
Jeong YI, Na HS, Cho KO, et al. Antitumor activity of adriamycin-incorporated polymeric micelles of poly(γ-benzyl l-glutamate)/poly(ethylene oxide). Int J Pharm. 2009;365:150–6.
He Q, Yuan WM, Liu J, et al. Study on in vivo distribution of liver-targeting nanoparticles encapsulating thymidine kinase gene (TK gene) in mice. J Mater Sci Mater Med. 2008;19:559–65.
Wu DQ, Lu B, Chang C, et al. Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterials. 2009;30:1363–71.
Stockert RJ, Morell AG. Hepatic binding protein: the galactose-sepcific receptor of mammalian hepatocytes. Hepatology. 1983;3:750–7.
Upadhyay KK, Bhatt AN, Mishra AK, et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials. 2010;31:2882–92.
Zweers MLT, Engbers GHM, Grijpma DW, et al. In vitro degradation of nanoparticles prepared from polymers based on dl-lactide, glycolide and poly(ethylene oxide). J Control Release. 2004;100:347–56.
Kataoka K, Matsumoto T, Yokoyama M, et al. Doxorubicin-loaded poly(ethylene glycol)-poly (β-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J Control Release. 2000;64:143–53.
Li YY, Zhang XZ, Cheng H, et al. Novel stimuli-responsive micelle self-assembled from Y-shaped P(UA-Y-NIPAAm) copolymer for drug delivery. Biomacromolecules. 2006;7:2956–60.
Shuai XT, Ai H, Nasongkla N, et al. Micellar carriers based on block copolymers of poly(ε- caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release. 2004;98:415–26.
Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm. 2008;364:328–43.
Shiah JG, Dvořák M, Kopečková P, et al. Biodistribution and antitumour efficacy of long- circulating N-(2-hydroxypropyl) methacrylamide copolymer-doxorubicin conjugates in nude mice. Eur J Cancer. 2001;37:131–9.
Zunino F, Marco AD, Zaccara A, Gambetta RA. The interaction of daunorubicin and doxorubicin with DNA and chromatin. Biochim Biophys Acta. 1980;607:206–14.
Itsubo M, Ishikawa T, Toda G, et al. Immunohistochemical study of expression and cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. Cancer. 1994;72:298–303.
Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release. 2004;96:273–83.
Acknowledgments
The authors gratefully acknowledge the National Natural Science Foundation of China (No. 50873048, No.51073080) and Key Project of Scientific and Technical Supporting Programs of Tianjin (No. 10ZCKFSY07500) for the financial support. The authors also appreciate Prof. Hua Tang and Mr. Min Liu for their assistance in the cytotoxicity assay.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huang, W., Wang, W., Wang, P. et al. Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier. J Mater Sci: Mater Med 22, 853–863 (2011). https://doi.org/10.1007/s10856-011-4262-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-011-4262-2